Scoring systems to screen for diabetic peripheral neuropathy (Q24198177)

2

0 references

Yuan Zhang

3

0 references

Yuansheng Huang

4

0 references

Tianpei Hong

5

0 references

Feng Sun

6

0 references

Linong Ji

7

0 references

Siyan Zhan

Cochrane Database of Systematic Reviews

8

0 references

publication date

5 March 2014

0 references

published in

0 references

cites work

Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Standards of medical care in diabetes--2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Treatment of symptomatic diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

The diabetic foot: grand overview, epidemiology and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Enhanced glucose control for preventing and treating diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Does this patient with diabetes have large-fiber peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetic neuropathy: a review emphasizing diagnostic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Clinical Trials of Diabetic Neuropathy: Past, Present, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Health-economic consequences of diabetic foot lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Case-control and two-gate designs in diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Obesity and hyperlipidemia are risk factors for early diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetic neuropathy--a continuing enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Classification, differential diagnosis, and staging of diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Total neuropathy score: validation and reliability study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

[Translation into Portuguese and assessment of the reliability of a scale for the diagnosis of diabetic distal polyneuropathy]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021

Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010974

7 January 2021